AGS-499

N/A

Report date: 2023/10/26 15:00:20
NME

Base Information

Drug NameAGS-499
Drug Alias NameAGS-499
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTelomerase activators
TargetsTelomerase
Therapy Area/IndicationsCardiovascular DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBen-Gurion University of the Negev
China Registration ClassN/A

Develop Information

Active CompaniesNeuromagen Pharma Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A